Press Release: Novartis: AveXis expands -2-

Central media line: +41 61 324 2200

E-mail: media.relations@novartis.com

Eric Althoff Farah Speer

Novartis Global Media Relations AveXis

+41 61 324 7999 (direct) +1 312 543 2881(mobile)

+41 79 593 4202 (mobile) fspeer259@avexis.com

eric.althoff@novartis.com

Novartis Investor Relations

Central investor relations line: +41 61 324 7944

E-mail: investor.relations@novartis.com

Central North America

Samir Shah +41 61 324 7944 Richard Pulik +1 212 830 2448

Pierre-Michel Bringer +41 61 324 1065 Cory Twining +1 212 830 2417

Thomas Hungerbuehler +41 61 324 8425

Isabella Zinck +41 61 324 7188

Media release (PDF): http://hugin.info/134323/R/2240368/883276.pdf

This announcement is distributed by West Corporation on behalf of West

Corporation clients.

The issuer of this announcement warrants that they are solely

responsible for the content, accuracy and originality of the information

contained therein.

Source: Novartis International AG via Globenewswire

--- End of Message ---

Novartis International AG

P.O. Box Basel Switzerland

WKN: 904278;ISIN: CH0012005267;

http://www.novartis.com

(END) Dow Jones Newswires

April 01, 2019 16:05 ET (20:05 GMT)